130 related articles for article (PubMed ID: 24583351)
1. Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)-9H- or 7H-purines against several human solid tumour cell lines.
Morales F; Ramírez A; Conejo-García A; Morata C; Marchal JA; Campos JM
Eur J Med Chem; 2014 Apr; 76():118-24. PubMed ID: 24583351
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines.
Conejo-García A; García-Rubiño ME; Marchal JA; Núñez MC; Ramírez A; Cimino S; García MÁ; Aránega A; Gallo MA; Campos JM
Eur J Med Chem; 2011 Sep; 46(9):3795-801. PubMed ID: 21645946
[TBL] [Abstract][Full Text] [Related]
3. New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine.
López-Cara LC; Conejo-García A; Marchal JA; Macchione G; Cruz-López O; Boulaiz H; García MA; Rodríguez-Serrano F; Ramírez A; Cativiela C; Jiménez AI; García-Ruiz JM; Choquesillo-Lazarte D; Aránega A; Campos JM
Eur J Med Chem; 2011 Jan; 46(1):249-58. PubMed ID: 21126804
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine.
Caba O; Díaz-Gavilán M; Rodríguez-Serrano F; Boulaiz H; Aránega A; Gallo MA; Marchal JA; Campos JM
Eur J Med Chem; 2011 Sep; 46(9):3802-9. PubMed ID: 21684047
[TBL] [Abstract][Full Text] [Related]
5. Regiospecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines.
Conejo-García A; Núñez MC; Marchal JA; Rodríguez-Serrano F; Aránega A; Gallo MA; Espinosa A; Campos JM
Eur J Med Chem; 2008 Aug; 43(8):1742-8. PubMed ID: 18069093
[TBL] [Abstract][Full Text] [Related]
6. Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells.
Morales F; Ramírez A; Morata-Tarifa C; Navarro SA; Marchal JA; Campos JM; Conejo-García A
Future Med Chem; 2017 Mar; 9(3):293-302. PubMed ID: 28176540
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines.
Núñez MC; Díaz-Gavilán M; Conejo-García A; Cruz-López O; Gallo MA; Espinosa A; Campos JM
Curr Med Chem; 2008; 15(25):2614-31. PubMed ID: 18855682
[TBL] [Abstract][Full Text] [Related]
8. Lignopurines: a new family of hybrids between cyclolignans and purines. Synthesis and biological evaluation.
Castro MÁ; Miguel del Corral JM; García PA; Rojo MV; Bento AC; Mollinedo F; Francesch AM; San Feliciano A
Eur J Med Chem; 2012 Dec; 58():377-89. PubMed ID: 23153810
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 2,6-disubstituted-9H-purine, 2,4-disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d]pyrimidine analogues as novel CHK1 inhibitors.
Tian C; Han Z; Li Y; Wang M; Yang J; Wang X; Zhang Z; Liu J
Eur J Med Chem; 2018 May; 151():836-848. PubMed ID: 29684894
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents.
Zhao TQ; Zhao YD; Liu XY; Wang B; Li ZH; He ZX; Zhang XH; Liang JJ; Ma LY; Liu HM
Eur J Med Chem; 2018 May; 151():327-338. PubMed ID: 29635165
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies.
Díaz-Gavilán M; Gómez-Vidal JA; Rodríguez-Serrano F; Marchal JA; Caba O; Aránega A; Gallo MA; Espinosa A; Campos JM
Bioorg Med Chem Lett; 2008 Feb; 18(4):1457-60. PubMed ID: 18194866
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel substituted purine derivatives and identification of the cell death mechanism.
Demir Z; Guven EB; Ozbey S; Kazak C; Atalay RC; Tuncbilek M
Eur J Med Chem; 2015 Jan; 89():701-20. PubMed ID: 25462277
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purines.
Díaz-Gavilán M; Conejo-García A; Cruz-López O; Núñez MC; Choquesillo-Lazarte D; González-Pérez JM; Rodríguez-Serrano F; Marchal JA; Aránega A; Gallo MA; Espinosa A; Campos JM
ChemMedChem; 2008 Jan; 3(1):127-35. PubMed ID: 18022976
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
Trávnícek Z; Szucová L; Popa I
J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
[TBL] [Abstract][Full Text] [Related]
15. New bis-N9-(methylphenylmethyl)purine derivatives: synthesis and antitumor activity.
Kode N; Chen L; Murthy D; Adewumi D; Phadtare S
Eur J Med Chem; 2007 Mar; 42(3):327-33. PubMed ID: 17166630
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of structurally simplified analogues of aplidinone A, a pro-apoptotic marine thiazinoquinone.
Aiello A; Fattorusso E; Luciano P; Menna M; Calzado MA; Muñoz E; Bonadies F; Guiso M; Sanasi MF; Cocco G; Nicoletti R
Bioorg Med Chem; 2010 Jan; 18(2):719-27. PubMed ID: 20031419
[TBL] [Abstract][Full Text] [Related]
17. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
18. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
19. Novel pyrimidine and purine derivatives of L-ascorbic acid: synthesis and biological evaluation.
Raić-Malić S; Hergold-Brundić A; Nagl A; Grdisa M; Pavelić K; De Clercq E; Mintas M
J Med Chem; 1999 Jul; 42(14):2673-8. PubMed ID: 10411487
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
Alafeefy AM; Ashour AE
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
